{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:56:44Z","timestamp":1790150204463,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In rheumatoid arthritis (RA), the proliferation of fibroblast-like synoviocytes (FLS) is the cause of chronic inflammation in joints and of joint damage. Delivery of the pro-apoptotic gene\n                    <jats:italic>PUMA<\/jats:italic>\n                    to FLS via human adenovirus type 5 (HAdV5) vectors has been tested as a therapeutic approach, but efficiency is hampered by low transduction, as FLS do not express HAdV5 receptors on the cell surface. Here we show that efficient transduction of PUMA in FLS can be achieved by conjugating HAdV5 to a baculovirus, which binds to the cell surface via the envelope glycoprotein Gp64. Intra-articular injection in an adjuvant-induced rat model of RA induces apoptosis of FLS, leading to significant decrease in joint inflammation, joint damage, and bone loss with improvement in joint function and mobility. Our results demonstrate the therapeutic potential of\n                    <jats:italic>PUMA<\/jats:italic>\n                    gene therapy as a local treatment in various forms of arthritis in which abnormal FLS proliferation is implicated.\n                  <\/jats:p>","DOI":"10.1038\/s41467-017-00142-1","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T09:48:17Z","timestamp":1500544097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["PUMA gene delivery to synoviocytes reduces inflammation and degeneration of arthritic joints"],"prefix":"10.1038","volume":"8","author":[{"given":"Saw-See","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1177-9497","authenticated-orcid":false,"given":"Hubert","family":"Marotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Courbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Firestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Boulanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Miossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"142_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.trsl.2013.01.002","volume":"161","author":"CH Evans","year":"2013","unstructured":"Evans, C. H., Ghivizzani, S. C. & Robbins, P. D. Arthritis gene therapy and its tortuous path into the clinic. Transl. Res. \n                           161, 205 (2013).","journal-title":"Transl. Res."},{"key":"142_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jbspin.2010.02.026","volume":"77","author":"H Marotte","year":"2010","unstructured":"Marotte, H. & Miossec, P. Biomarkers for prediction of TNFalpha blockers response in rheumatoid arthritis. Joint Bone Spine \n                           77, 297 (2010).","journal-title":"Joint Bone Spine"},{"key":"142_CR3","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/art.1780391103","volume":"39","author":"GS Firestein","year":"1996","unstructured":"Firestein, G. S. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum. \n                           39, 1781 (1996).","journal-title":"Arthritis Rheum."},{"key":"142_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.clim.2004.12.009","volume":"115","author":"A Mor","year":"2005","unstructured":"Mor, A., Abramson, S. B. & Pillinger, M. H. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin. Immunol. \n                           115, 118 (2005).","journal-title":"Clin. Immunol."},{"key":"142_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein, G. S. Evolving concepts of rheumatoid arthritis. Nature. \n                           423, 356 (2003).","journal-title":"Nature."},{"key":"142_CR6","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1002\/art.22853","volume":"56","author":"W Kammouni","year":"2007","unstructured":"Kammouni, W. et al. Regulation of apoptosis in fibroblast-like synoviocytes by the hypoxia-induced Bcl-2 family member Bcl-2\/adenovirus E1B 19-kd protein-interacting protein 3. Arthritis. Rheum. \n                           56, 2854 (2007).","journal-title":"Arthritis. Rheum."},{"key":"142_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.berh.2010.02.002","volume":"24","author":"M Niedermeier","year":"2010","unstructured":"Niedermeier, M., Pap, T. & Korb, A. Therapeutic opportunities in fibroblasts in inflammatory arthritis. Best Pract. Res. Clin. Rheumatol. \n                           24, 527 (2010).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"142_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/art.21631","volume":"54","author":"HS Cha","year":"2006","unstructured":"Cha, H. S., Rosengren, S., Boyle, D. L. & Firestein, G. S. PUMA regulation and proapoptotic effects in fibroblast-like synoviocytes. Arthritis Rheum. \n                           54, 587 (2006).","journal-title":"Arthritis Rheum."},{"key":"142_CR9","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1186\/ar2052","volume":"8","author":"X You","year":"2006","unstructured":"You, X., Boyle, D. L., Hammaker, D. & Firestein, G. S. PUMA-mediated apoptosis in fibroblast-like synoviocytes does not require p53. Arthritis Res. Ther. \n                           8, R157 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"142_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/ar2563","volume":"11","author":"CH Evans","year":"2009","unstructured":"Evans, C. H., Ghivizzani, S. C. & Robbins, P. D. Gene therapy of the rheumatic diseases: 1998 to 2008. Arthritis Res. Ther. \n                           11, 209 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"142_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.berh.2010.02.001","volume":"24","author":"C Jorgensen","year":"2010","unstructured":"Jorgensen, C. & Apparailly, F. Prospects for gene therapy in inflammatory arthritis. Best Pract. Res. Clin. Rheumatol. \n                           24, 541 (2010).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"142_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1165\/rcmb.4841","volume":"27","author":"F Gaden","year":"2002","unstructured":"Gaden, F. et al. Mechanism of restriction of normal and cystic fibrosis transmembrane conductance regulator-deficient human tracheal gland cells to adenovirus (Ad) infection and Ad-mediated gene transfer. Am. J. Respir. Cell Mol. Biol. \n                           27, 628 (2002).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"142_CR13","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.4049\/jimmunol.175.11.7687","volume":"175","author":"M-L Toh","year":"2005","unstructured":"Toh, M.-L. et al. Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of RGD- and non-RGD-binding integrins. J. Immunol. \n                           175, 7687 (2005).","journal-title":"J. Immunol."},{"key":"142_CR14","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.1128\/JVI.00012-09","volume":"83","author":"O Granio","year":"2009","unstructured":"Granio, O. et al. Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on Coxsackie B-adenovirus receptor-pseudotyped baculovirus. J. Virol. \n                           83, 6048 (2009).","journal-title":"J. Virol."},{"key":"142_CR15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1172\/JCI117685","volume":"95","author":"J Dechanet","year":"1995","unstructured":"Dechanet, J., Merville, P., Durand, I., Banchereau, J. & Miossec, P. The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J. Clin. Invest. \n                           95, 456 (1995).","journal-title":"J. Clin. Invest."},{"key":"142_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/1529-0131(200103)44:3<570::AID-ANR105>3.0.CO;2-Y","volume":"44","author":"PH Goossens","year":"2001","unstructured":"Goossens, P. H. et al. Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber. Arthritis Rheum. \n                           44, 570 (2001).","journal-title":"Arthritis Rheum."},{"key":"142_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0065-3527(06)68008-1","volume":"68","author":"YC Hu","year":"2006","unstructured":"Hu, Y. C. Baculovirus vectors for gene therapy. Adv. Virus. Res. \n                           68, 287 (2006).","journal-title":"Adv. Virus. Res."},{"key":"142_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2174\/156652308783688509","volume":"8","author":"YC Hu","year":"2008","unstructured":"Hu, Y. C. Baculoviral vectors for gene delivery: a review. Curr. Gene Ther. \n                           8, 54 (2008).","journal-title":"Curr. Gene Ther."},{"key":"142_CR19","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/art.21926","volume":"54","author":"ML Toh","year":"2006","unstructured":"Toh, M. L. et al. Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment. Arthritis Rheum. \n                           54, 2109 (2006).","journal-title":"Arthritis Rheum."},{"key":"142_CR20","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. Rheumatoid arthritis classification criteria: an American College of rheumatology\/european league against rheumatism collaborative initiative. Arthritis Rheum. \n                           62, 2569 (2010).","journal-title":"Arthritis Rheum."},{"key":"142_CR21","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1089\/hum.1998.9.16-2363","volume":"9","author":"S Hemmi","year":"1998","unstructured":"Hemmi, S., Geertsen, R., Mezzacasa, A., Peter, I. & Dummer, R. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum. Gene. Ther. \n                           9, 2363 (1998).","journal-title":"Hum. Gene. Ther."},{"key":"142_CR22","doi-asserted-by":"publisher","first-page":"e2894","DOI":"10.1371\/journal.pone.0002894","volume":"3","author":"L Franqueville","year":"2008","unstructured":"Franqueville, L. et al. Protein crystals in adenovirus type 5-infected cells: requirements for intranuclear crystallogenesis, structural and functional analysis. PLoS ONE \n                           3, e2894 (2008).","journal-title":"PLoS ONE"},{"key":"142_CR23","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1128\/JVI.78.13.7227-7247.2004","volume":"78","author":"F Gaden","year":"2004","unstructured":"Gaden, F. et al. Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells. J. Virol. \n                           78, 7227 (2004).","journal-title":"J. Virol."},{"key":"142_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1165\/rcmb.2007-0026TE","volume":"37","author":"O Granio","year":"2007","unstructured":"Granio, O. et al. Cellular localization and activity of Ad-delivered GFP-CFTR in airway epithelial and tracheal cells. Am. J. Respir. Cell Mol. Biol. \n                           37, 631 (2007).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"142_CR25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S1525-0016(03)00067-4","volume":"7","author":"SS Hong","year":"2003","unstructured":"Hong, S. S., Magnusson, M. K., Henning, P., Lindholm, L. & Boulanger, P. A. Adenovirus stripping: a versatile method to generate adenovirus vectors with new cell target specificity. Mol. Ther. \n                           7, 692 (2003).","journal-title":"Mol. Ther."},{"key":"142_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/rheumatology\/kep397","volume":"49","author":"H Marotte","year":"2010","unstructured":"Marotte, H., Ruth, J. H., Campbell, P. L., Koch, A. E. & Ahmed, S. Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis. Rheumatology. \n                           49, 467 (2010).","journal-title":"Rheumatology."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00142-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00142-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00142-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T14:38:30Z","timestamp":1671719910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00142-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["142"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-00142-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727846167.793538310","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]},"assertion":[{"value":"1 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}